Sökning: onr:"swepub:oai:hhs.se:1155079000006056" >
Towards Better Phar...
Towards Better Pharmaceutical Provision in Europe—Who Decides the Future?
-
- Spanic, Tanja (författare)
- Europa Donna, The European Breast Cancer Coalition
-
- Apostolidis, Kathi (författare)
- European Cancer Patient Coalition
-
- Curigiliano, Guiseppe (författare)
- University of Milan (IT)
-
visa fler...
-
- Chorostowska-Wynimko, Joanna (författare)
- National Institute of Tuberculosis and Lung Diseases
-
- Dauben, Hans-Peter (författare)
- EuroScan International Network
-
- Lal, Jonathan (författare)
- Jacob Institute of Biotechnology and Bioengineering
-
- Dziadziuszko, Rafal (författare)
- Medical University of Gdansk
-
- Mayer-Nicolai, Christine (författare)
- Global Regulatory and Scientific Policy
-
- Kozaric, Marta (författare)
- European Alliance for Personalised Medicine
-
- Gutierrez-Ibarluzea, Inaki (författare)
- Basque Foundation for Health Innovation and Research
-
- Jönsson, Bengt (författare)
- Stockholm School of Economics,Handelshögskolan i Stockholm
-
- Fandel, Marie-Helene (författare)
- Corporate Public Affairs
-
- Lopert, Ruth (författare)
- Organisation for Economic Co-operation and Development
-
- Horgan, Denis (författare)
- European Alliance for Personalised Medicine
-
visa färre...
-
(creator_code:org_t)
- 2022-08-22
- 2022
- Engelska.
-
Ingår i: Healthcare (Switzerland). - : MDPI. - 2227-9032 .- 2227-9032. ; 10:8
- Relaterad länk:
-
https://research.hhs... (primary) (Object in context)
-
visa fler...
-
https://research.hhs...
-
https://doi.org/10.3...
-
visa färre...
Abstract
Ämnesord
Stäng
- Significant progress has been achieved in human health in the European Union in recent years. New medicines, vaccines, and treatments have been developed to tackle some of the leading causes of disease and life-threatening illnesses. It is clear that investment in research and development (R&D) for innovative medicines and treatments is essential for making progress in preventing and treating diseases. Ahead of the legislative process, which should begin by the end of 2022, discussions focus on how Europe can best promote the huge potential benefits of new science and technology within the regulatory framework. The challenges in European healthcare were spelled out by the panellists at the roundtable organised by European Alliance for Personalised Medicine (EAPM). Outcomes from panellists’ discussions have been summarized and re-arranged in this paper under five headings: innovation, unmet medical need, access, security of supply, adapting to progress, and efficiency. Some of the conclusions that emerged from the panel are a call for a better overall holistic vision of the future of pharmaceuticals and health in Europe and a collaborative effort among all stakeholders, seeing the delivery of medicines as part of a broader picture of healthcare. © 2022 by the authors.
Ämnesord
- MEDICIN OCH HÄLSOVETENSKAP -- Hälsovetenskap (hsv//swe)
- MEDICAL AND HEALTH SCIENCES -- Health Sciences (hsv//eng)
Publikations- och innehållstyp
- art (ämneskategori)
- ref (ämneskategori)
Hitta via bibliotek
Till lärosätets databas
- Av författaren/redakt...
-
Spanic, Tanja
-
Apostolidis, Kat ...
-
Curigiliano, Gui ...
-
Chorostowska-Wyn ...
-
Dauben, Hans-Pet ...
-
Lal, Jonathan
-
visa fler...
-
Dziadziuszko, Ra ...
-
Mayer-Nicolai, C ...
-
Kozaric, Marta
-
Gutierrez-Ibarlu ...
-
Jönsson, Bengt
-
Fandel, Marie-He ...
-
Lopert, Ruth
-
Horgan, Denis
-
visa färre...
- Om ämnet
-
- MEDICIN OCH HÄLSOVETENSKAP
-
MEDICIN OCH HÄLS ...
-
och Hälsovetenskap
- Artiklar i publikationen
-
Healthcare (Swit ...
- Av lärosätet
-
Handelshögskolan i Stockholm